Targeted therapies for renal cell carcinoma:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Future Medicine Ltd
c2011
|
| Schriftenreihe: | Future Science Group eBook collection
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Beschreibung: | Includes bibliographical references and index Targeted therapy for renal cell carcinoma / Ronald M. Bukowski -- Overview of renal cell carcinoma pathways and drug targets / Bernard Escudier -- mTOR in renal cell cancer: modulator of tumor biology and therapeutic target / Piotr J. Wysocki -- VEGF inhibitors / Toni K. Choueiri & Ali R. Golshayan -- VEGFR/PDGFR inhibitors in RCC / Jean S.Z. Lee & Tim Eisen -- Next-generation immunotherapy: CTLA-4 and PD-1 inhibitors / Daniel Y.C. Heng -- EGF receptor inhibitors / Marine Gross-Goupil & Alain Ravaud -- Cytokines / Alexandra Leary, James M.G. Larkin & Lisa M. Pickering -- Vaccination / Robert J Amato -- Evidence-based therapy of non-clear-cell and sarcomatoid renal cell carcinoma / Elan Diamond, Naveed H. Akhtar, Scott T. Tagawa & David M. Nanus -- Bisphosphonates in renal cell carcinoma: palliation versus antitumor effects / Saby George & Roberto Pili -- Combination therapy and future directions in renal cell carcinoma / Bernard Escudier & Camillo Porta |
| Beschreibung: | 1 electronic text (145 p.) col. ill., digital file |
| ISBN: | 9781780840024 9781780840031 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV039836394 | ||
| 003 | DE-604 | ||
| 005 | 20121105 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 120124s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9781780840024 |c pdf |9 978-1-78084-002-4 | ||
| 020 | |a 9781780840031 |9 978-1-78084-003-1 | ||
| 024 | 7 | |a 10.2217/9781780840024 |2 doi | |
| 035 | |a (OCoLC)759716166 | ||
| 035 | |a (DE-599)BVBBV039836394 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.99/461 |2 20 | |
| 084 | |a XH 7865 |0 (DE-625)152946:13144 |2 rvk | ||
| 245 | 1 | 0 | |a Targeted therapies for renal cell carcinoma |c editor, Ronald M. Bukowski |
| 264 | 1 | |a London |b Future Medicine Ltd |c c2011 | |
| 300 | |a 1 electronic text (145 p.) |b col. ill., digital file | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Future Science Group eBook collection | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Targeted therapy for renal cell carcinoma / Ronald M. Bukowski -- Overview of renal cell carcinoma pathways and drug targets / Bernard Escudier -- mTOR in renal cell cancer: modulator of tumor biology and therapeutic target / Piotr J. Wysocki -- VEGF inhibitors / Toni K. Choueiri & Ali R. Golshayan -- VEGFR/PDGFR inhibitors in RCC / Jean S.Z. Lee & Tim Eisen -- Next-generation immunotherapy: CTLA-4 and PD-1 inhibitors / Daniel Y.C. Heng -- EGF receptor inhibitors / Marine Gross-Goupil & Alain Ravaud -- Cytokines / Alexandra Leary, James M.G. Larkin & Lisa M. Pickering -- Vaccination / Robert J Amato -- Evidence-based therapy of non-clear-cell and sarcomatoid renal cell carcinoma / Elan Diamond, Naveed H. Akhtar, Scott T. Tagawa & David M. Nanus -- Bisphosphonates in renal cell carcinoma: palliation versus antitumor effects / Saby George & Roberto Pili -- Combination therapy and future directions in renal cell carcinoma / Bernard Escudier & Camillo Porta | ||
| 650 | 4 | |a Renal cell carcinoma / Treatment | |
| 650 | 4 | |a Kidneys / Cancer / Treatment | |
| 650 | 0 | 7 | |a Nierenkrebs |0 (DE-588)4171882-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 689 | 0 | 0 | |a Nierenkrebs |0 (DE-588)4171882-3 |D s |
| 689 | 0 | 1 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Bukowski, Ronald M. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840024 |x Verlag |3 Volltext |
| 912 | |a ZDB-81-FSG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024696382 | ||
| 966 | e | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840024 |l UBR01 |p ZDB-81-FSG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804148766511464448 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV039836394 |
| classification_rvk | XH 7865 |
| collection | ZDB-81-FSG |
| ctrlnum | (OCoLC)759716166 (DE-599)BVBBV039836394 |
| dewey-full | 616.99/461 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/461 |
| dewey-search | 616.99/461 |
| dewey-sort | 3616.99 3461 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02689nmm a2200469zc 4500</leader><controlfield tag="001">BV039836394</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20121105 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">120124s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840024</subfield><subfield code="c">pdf</subfield><subfield code="9">978-1-78084-002-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840031</subfield><subfield code="9">978-1-78084-003-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2217/9781780840024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)759716166</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039836394</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/461</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 7865</subfield><subfield code="0">(DE-625)152946:13144</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeted therapies for renal cell carcinoma</subfield><subfield code="c">editor, Ronald M. Bukowski</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Future Medicine Ltd</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic text (145 p.)</subfield><subfield code="b">col. ill., digital file</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Future Science Group eBook collection</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Targeted therapy for renal cell carcinoma / Ronald M. Bukowski -- Overview of renal cell carcinoma pathways and drug targets / Bernard Escudier -- mTOR in renal cell cancer: modulator of tumor biology and therapeutic target / Piotr J. Wysocki -- VEGF inhibitors / Toni K. Choueiri & Ali R. Golshayan -- VEGFR/PDGFR inhibitors in RCC / Jean S.Z. Lee & Tim Eisen -- Next-generation immunotherapy: CTLA-4 and PD-1 inhibitors / Daniel Y.C. Heng -- EGF receptor inhibitors / Marine Gross-Goupil & Alain Ravaud -- Cytokines / Alexandra Leary, James M.G. Larkin & Lisa M. Pickering -- Vaccination / Robert J Amato -- Evidence-based therapy of non-clear-cell and sarcomatoid renal cell carcinoma / Elan Diamond, Naveed H. Akhtar, Scott T. Tagawa & David M. Nanus -- Bisphosphonates in renal cell carcinoma: palliation versus antitumor effects / Saby George & Roberto Pili -- Combination therapy and future directions in renal cell carcinoma / Bernard Escudier & Camillo Porta</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Renal cell carcinoma / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kidneys / Cancer / Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nierenkrebs</subfield><subfield code="0">(DE-588)4171882-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Nierenkrebs</subfield><subfield code="0">(DE-588)4171882-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bukowski, Ronald M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840024</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-81-FSG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024696382</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840024</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-81-FSG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV039836394 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:12:21Z |
| institution | BVB |
| isbn | 9781780840024 9781780840031 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024696382 |
| oclc_num | 759716166 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 electronic text (145 p.) col. ill., digital file |
| psigel | ZDB-81-FSG |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Future Medicine Ltd |
| record_format | marc |
| series2 | Future Science Group eBook collection |
| spelling | Targeted therapies for renal cell carcinoma editor, Ronald M. Bukowski London Future Medicine Ltd c2011 1 electronic text (145 p.) col. ill., digital file txt rdacontent c rdamedia cr rdacarrier Future Science Group eBook collection Includes bibliographical references and index Targeted therapy for renal cell carcinoma / Ronald M. Bukowski -- Overview of renal cell carcinoma pathways and drug targets / Bernard Escudier -- mTOR in renal cell cancer: modulator of tumor biology and therapeutic target / Piotr J. Wysocki -- VEGF inhibitors / Toni K. Choueiri & Ali R. Golshayan -- VEGFR/PDGFR inhibitors in RCC / Jean S.Z. Lee & Tim Eisen -- Next-generation immunotherapy: CTLA-4 and PD-1 inhibitors / Daniel Y.C. Heng -- EGF receptor inhibitors / Marine Gross-Goupil & Alain Ravaud -- Cytokines / Alexandra Leary, James M.G. Larkin & Lisa M. Pickering -- Vaccination / Robert J Amato -- Evidence-based therapy of non-clear-cell and sarcomatoid renal cell carcinoma / Elan Diamond, Naveed H. Akhtar, Scott T. Tagawa & David M. Nanus -- Bisphosphonates in renal cell carcinoma: palliation versus antitumor effects / Saby George & Roberto Pili -- Combination therapy and future directions in renal cell carcinoma / Bernard Escudier & Camillo Porta Renal cell carcinoma / Treatment Kidneys / Cancer / Treatment Nierenkrebs (DE-588)4171882-3 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf Electronic books Nierenkrebs (DE-588)4171882-3 s Targeted drug delivery (DE-588)4302415-4 s DE-604 Bukowski, Ronald M. Sonstige oth http://www.futuremedicine.com/doi/book/10.2217/9781780840024 Verlag Volltext |
| spellingShingle | Targeted therapies for renal cell carcinoma Renal cell carcinoma / Treatment Kidneys / Cancer / Treatment Nierenkrebs (DE-588)4171882-3 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
| subject_GND | (DE-588)4171882-3 (DE-588)4302415-4 |
| title | Targeted therapies for renal cell carcinoma |
| title_auth | Targeted therapies for renal cell carcinoma |
| title_exact_search | Targeted therapies for renal cell carcinoma |
| title_full | Targeted therapies for renal cell carcinoma editor, Ronald M. Bukowski |
| title_fullStr | Targeted therapies for renal cell carcinoma editor, Ronald M. Bukowski |
| title_full_unstemmed | Targeted therapies for renal cell carcinoma editor, Ronald M. Bukowski |
| title_short | Targeted therapies for renal cell carcinoma |
| title_sort | targeted therapies for renal cell carcinoma |
| topic | Renal cell carcinoma / Treatment Kidneys / Cancer / Treatment Nierenkrebs (DE-588)4171882-3 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
| topic_facet | Renal cell carcinoma / Treatment Kidneys / Cancer / Treatment Nierenkrebs Targeted drug delivery |
| url | http://www.futuremedicine.com/doi/book/10.2217/9781780840024 |
| work_keys_str_mv | AT bukowskironaldm targetedtherapiesforrenalcellcarcinoma |